These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31562963)

  • 21. [Clinical efficacy of different vascular reconstruction on adult moyamoya disease].
    Pan SJ; Zhang Y; Hou Y; Wang JF; Chai HF; Zhao ZX; Hu XM; Zang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(13):998-1002. PubMed ID: 30955312
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome.
    Kuroda S; Houkin K; Ishikawa T; Nakayama N; Iwasaki Y
    Neurosurgery; 2010 Jun; 66(6):1093-101; discussion 1101. PubMed ID: 20495424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
    Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
    J Neurosurg Pediatr; 2019 Apr; 23(4):486-492. PubMed ID: 30738390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superficial temporal artery-middle cerebral artery bypass combined with encephalo-duro-myo-synangiosis in treating moyamoya disease: surgical techniques, indications and midterm follow-up results.
    Xu B; Song DL; Mao Y; Gu YX; Xu H; Liao YJ; Liu CH; Zhou LF
    Chin Med J (Engl); 2012 Dec; 125(24):4398-405. PubMed ID: 23253709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined revascularization surgery for childhood moyamoya disease: STA-MCA and encephalo-duro-arterio-myo-synangiosis.
    Houkin K; Kamiyama H; Takahashi A; Kuroda S; Abe H
    Childs Nerv Syst; 1997 Jan; 13(1):24-9. PubMed ID: 9083698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of cerebral infarction after bypass surgery in adult moyamoya disease: using pulsatility index on TCD.
    Ding J; Chang X; Ma P; Yang G; Zhang R; Li Y; Lei T; Mu L; Zhang X; Li Z; Tang J; Tang Z
    BMC Neurol; 2024 Jun; 24(1):198. PubMed ID: 38867178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'.
    Tu XK; Fujimura M; Rashad S; Mugikura S; Sakata H; Niizuma K; Tominaga T
    Neurosurg Rev; 2017 Jul; 40(3):507-512. PubMed ID: 28357585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified encephalo-duro-periosteal-synangiosis (EDPS) for the revascularization of anterior cerebral artery territory in moyamoya disease: A single-center experience.
    Zhao Y; Yu S; Li J; Lu J; Zhang Q; Zhang D; Wang R; Zhao Y
    Clin Neurol Neurosurg; 2019 Mar; 178():86-92. PubMed ID: 30763783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent Diffusion Coefficient and Transient Neurological Deficit after Revascularization Surgery in Moyamoya Disease.
    Araki Y; Takagi Y; Fushimi Y; Arakawa Y; Funaki T; Kikuchi T; Takahashi JC; Togashi K; Miyamoto S
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2054-9. PubMed ID: 26166418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.
    Fujimura M; Niizuma K; Endo H; Sato K; Inoue T; Shimizu H; Tominaga T
    Neurol Res; 2015 Feb; 37(2):131-8. PubMed ID: 25082550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis.
    Isono M; Ishii K; Kamida T; Inoue R; Fujiki M; Kobayashi H
    Pediatr Neurosurg; 2002 Jan; 36(1):14-21. PubMed ID: 11818741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
    Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
    Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical results in pediatric moyamoya disease: angiographic revascularization and the clinical results.
    Kim DS; Kang SG; Yoo DS; Huh PW; Cho KS; Park CK
    Clin Neurol Neurosurg; 2007 Feb; 109(2):125-31. PubMed ID: 16872739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous superficial temporal artery to middle cerebral or anterior cerebral artery bypass with pan-synangiosis for Moyamoya disease covering both anterior and middle cerebral artery territories.
    Ishikawa T; Kamiyama H; Kuroda S; Yasuda H; Nakayama N; Takizawa K
    Neurol Med Chir (Tokyo); 2006 Sep; 46(9):462-8. PubMed ID: 16998283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving Indirect Revascularization for Effective Treatment of Adult Moyamoya Disease: A Prospective Clinical, Cerebral Angiographic, and Perfusion Study.
    Chou SC; Chen YF; Lee CW; Hsu HC; Wang KC; Yang SH; Liu HM; Kuo MF
    World Neurosurg; 2018 Nov; 119():e180-e191. PubMed ID: 30031192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial Spin Labeling MRI for Quantitative Assessment of Cerebral Perfusion Before and After Cerebral Revascularization in Children with Moyamoya Disease.
    Ha JY; Choi YH; Lee S; Cho YJ; Cheon JE; Kim IO; Kim WS
    Korean J Radiol; 2019 Jun; 20(6):985-996. PubMed ID: 31132824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enlarged Encephalo-Duro-Myo-Synangiosis Treatment for Moyamoya Disease in Young Children.
    Shen W; Xu B; Li H; Gao X; Liao Y; Shi W; Zhao R; Zhang Y
    World Neurosurg; 2017 Oct; 106():9-16. PubMed ID: 28645592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.